BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10517447)

  • 61. Computerized tomography in ovarian cancer.
    Solomon A; Brenner HJ; Rubinstein Z; Chaitchik S; Morag B
    Gynecol Oncol; 1983 Feb; 15(1):48-55. PubMed ID: 6822367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancer.
    Stehman FB; Calkins AR; Wass JL; Smirz LR; Sutton GP; Ehrlich CE
    Gynecol Oncol; 1988 Jan; 29(1):37-42. PubMed ID: 3338662
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A 61-year-old woman with jejunal lymphatic malformation visualized on computed tomography: a case report.
    Rupasinghe M; Houshyar R; Chahine C; Bui TL; Glavis-Bloom J; Cheng C; Tseng J
    J Med Case Rep; 2021 May; 15(1):302. PubMed ID: 34039402
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Computed tomography in ovarian carcinoma: patterns of disease and limitations.
    Mamtora H; Isherwood I
    Clin Radiol; 1982 Mar; 33(2):165-71. PubMed ID: 7067349
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Abdominal ultrasound in advanced ovarian carcinoma.
    Paling MR; Shawker TH
    J Clin Ultrasound; 1981 Oct; 9(8):435-41. PubMed ID: 6795238
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhancing ascites: an aid to CT diagnosis.
    Wise SW; DeMeo JH; Austin RF
    Abdom Imaging; 1996; 21(1):67-8. PubMed ID: 8672977
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intracavitary mass in echocardiography: A rare manifestation of serous ovarian carcinoma.
    Mendez-Toro A; Linares-Vaca AF
    Rev Port Cardiol (Engl Ed); 2021 Sep; 40(9):701-702. PubMed ID: 34503713
    [No Abstract]   [Full Text] [Related]  

  • 68. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.
    Boehm KM; Aherne EA; Ellenson L; Nikolovski I; Alghamdi M; Vázquez-García I; Zamarin D; Long Roche K; Liu Y; Patel D; Aukerman A; Pasha A; Rose D; Selenica P; Causa Andrieu PI; Fong C; Capanu M; Reis-Filho JS; Vanguri R; Veeraraghavan H; Gangai N; Sosa R; Leung S; McPherson A; Gao J; ; Lakhman Y; Shah SP
    Nat Cancer; 2022 Jun; 3(6):723-733. PubMed ID: 35764743
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Can pre-operative computed tomography predict resectability of ovarian carcinoma at primary laparotomy?
    Naik R; de Barros Lopes A; Hatem H; Godfrey K; Tailor A; Monaghan JM
    BJOG; 2003 Aug; 110(8):788. PubMed ID: 12892700
    [No Abstract]   [Full Text] [Related]  

  • 70. Can computed tomography substitute for second-look operation in ovarian carcinoma?
    Stern J; Buscema J; Rosenshein N; Siegelman S
    Gynecol Oncol; 1981 Feb; 11(1):82-8. PubMed ID: 7203166
    [No Abstract]   [Full Text] [Related]  

  • 71. Proliferative ovarian tumors: with special reference to the incidence of previous pelvic surgery and/or irradiation in carcinoma.
    DIMASI FT; GROGAN RH
    Obstet Gynecol; 1960 Mar; 15():315-9. PubMed ID: 13816789
    [No Abstract]   [Full Text] [Related]  

  • 72. Chemotherapeutic Effect on Ovarian Stroma and Tumor Cells Which Make Problem in Diagnosis and Staging of Tumor.
    Nasirian N; Elmizadeh K
    Iran J Pathol; 2021; 16(4):465-466. PubMed ID: 34567200
    [No Abstract]   [Full Text] [Related]  

  • 73. Imaging of Peritoneal Carcinomatosis in Advanced Ovarian Cancer: CT, MRI, Radiomic Features and Resectability Criteria.
    Miceli V; Gennarini M; Tomao F; Cupertino A; Lombardo D; Palaia I; Curti F; Riccardi S; Ninkova R; Maccioni F; Ricci P; Catalano C; Rizzo SMR; Manganaro L
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The circular RNA expression profile in ovarian serous cystadenocarcinoma reveals a complex circRNA-miRNA regulatory network.
    Zhuang M; Zhao J; Wu J; Fu S; Han P; Song X
    BMC Med Genomics; 2021 Dec; 14(Suppl 2):276. PubMed ID: 34857007
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identifying the deceiver: the non-neoplastic mimickers of genital system neoplasms.
    Onder O; Karaosmanoglu AD; Kraeft J; Uysal A; Karcaaltincaba M; Akata D; Ozmen MN; Hahn PF
    Insights Imaging; 2021 Jul; 12(1):95. PubMed ID: 34232414
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CT texture analysis in histological classification of epithelial ovarian carcinoma.
    An H; Wang Y; Wong EMF; Lyu S; Han L; Perucho JAU; Cao P; Lee EYP
    Eur Radiol; 2021 Jul; 31(7):5050-5058. PubMed ID: 33409777
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.
    Yu XP; Liu Y; Jiao JW; Yang HJ; Wang RJ; Zhang S
    Med Sci Monit; 2020 Aug; 26():e924497. PubMed ID: 32801292
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A rare case of a primary retroperitoneal mucinous cystic tumour with borderline malignancy and literature review.
    Chaves MM; Castro R; Mota-Vieira L; Carneiro V
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31488447
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of Imaging in Peritoneal Surface Malignancies.
    Krishnamurthy S; Balasubramaniam R
    Indian J Surg Oncol; 2016 Dec; 7(4):441-452. PubMed ID: 27872533
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.